The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Cable, Jemma C ^a   Tan, Garry D ^b   Alexander, Stephen Ph ^c   O'Sullivan, Saoirse E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adipocyte; Adipose; Endocannabinoid; Fatty acid amide hydrolase (FAAH); Human; Monoacylglycerol lipase (MGL); Obesity; Rat; Type 2 diabetes

Indexed keywords

ACYLGLYCEROL LIPASE; CHOLESTEROL; ENDOCANNABINOID; FATTY ACID AMIDASE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; HYDROLASE;

ABDOMINAL FAT; ADIPOCYTE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; ENZYME ACTIVITY; EPIDIDYMIS FAT; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; RAT; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; SURGICAL PATIENT; TRIACYLGLYCEROL BLOOD LEVEL; ZUCKER DIABETIC FATTY RAT; ZUCKER RAT; ADIPOSE TISSUE; BODY WEIGHT; DYSLIPIDEMIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OMENTUM; ZUCKER FATTY RAT; ZUCKER LEAN RAT;

ANIMALIA; RATTUS;

ADIPOCYTES, WHITE; ADULT; AMIDOHYDROLASES; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; ENDOCANNABINOIDS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MONOACYLGLYCEROL LIPASES; OBESITY; RATS; RATS, ZUCKER;

EID: 84899494332     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-43     Document Type: Article

References (29)

1. Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle. Silvestri C, Ligresti A, Di Marzo V, Rev Endocr Metab Disord 2011 12 3 153 62 10.1007/s11154-011-9167-3 21336842
2. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Di Marzo V, Piscitelli F, Mechoulam R, Handb Exp Pharmacol 2011 203 75 104 10.1007/978-3-642-17214-4-4 21484568
3. New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance. Lipina C, Rastedt W, Irving AJ, Hundal HS, Bioessays 2012 34 8 681 91 10.1002/bies.201200031 22674489
4. Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight. Engeli S, Handb Exp Pharmacol 2012 209 357 81 10.1007/978-3-642-24716-3-17 22249824
5. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Devane W, Hanus L, Breuer A, Pertwee R, Stevenson L, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R, Science 1992 258 1946 1949 10.1126/science.1470919 1470919
6. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Mechoulam R, Ben-Shabat S, Hanus L, Liumsky M, Kaminski N, Schatz A, Gopher A, Almog S, Martin B, Compton D, Pertwee R, Griffin G, Bayewitch M, Barg J, Vogel Z, Biochem Pharmacol 1995 50 83 90 7605349
7. 2-arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K, Biochem Biophys Res Commun 1995 215 89 97 10.1006/bbrc.1995.2437 7575630
8. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Cravatt B, Giang D, Mayfield S, Boer D, Lerner R, Gilula N, Nature 1996 384 83 87 10.1038/384083a0 8900284
9. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Dinh T, Freund T, Piomelli D, Chem Phys Lipids 2002 121 149 158 10.1016/S0009-3084(02)00150-0 12505697
10. Activation of the Peripheral Endocannabinoid System in Human Obesity. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Janke J, Batkai S, Pacher P, Harvey-White J, Luft F, Sharma A, Jordan J, Diabetes 2005 54 2838 2834 10.2337/diabetes.54.10.2838 16186383
11. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Bluher M, Engeli S, Kloting N, Berndt J, Fasshauer M, Batkai S, Pacher P, Schon M, Jordan J, Stumvoli M, Diabetes 2006 55 3053 3060 10.2337/db06-0812 17065342
12. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Cote M, Matias I, Lemieux I, Petrosino S, Almeras N, Despres J-P, Di Marzo V, Int J Obes (Lond) 2007 31 692 699 17224929
13. Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. Grapov D, Adams SH, Pedersen TL, Garvey WT, Newman JW, PLoS One 2012 7 11 48852 10.1371/journal.pone.0048852 23144998
14. The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans. Cable JC, Tan GD, Alexander SP, O'Sullivan SE, Lipids Health Dis 2011 10 129 10.1186/1476-511X-10-129 21813022
15. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R, Roche R, Maj M, Pagotto U, Monteleone P, Di Marzo V, J Clin Endocrinol Metab 2006 91 3171 80 10.1210/jc.2005-2679 16684820
16. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. Annuzzi G, Piscitelli F, Di Marino L, Patti L, Giacco R, Costabile G, Bozzetto L, Riccardi G, Verde R, Petrosino S, Rivellese AA, Di Marzo V, Lipids Health Dis 2010 9 43 10.1186/1476-511X-9-43 20426869
17. Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals. Murdolo G, Kempf K, Hammarstedt A, Herder C, Smith U, Jansson PA, J Endocrinol Invest 2007 30 C17 21 17923791
18. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Wajchenber BL, Endocr Rev 2000 21 697 738 10.1210/edrv.21.6.0415 11133069
19. Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients. Sarzani R, Bordicchia M, Marcucci P, Bedetta S, Santini S, Giovagnoli A, Scappini L, Minardi D, Muzzonigro G, Dessì-Fulgheri P, Rappelli A, Metabolism 2009 58 361 7 10.1016/j.metabol.2008.10.009 19217452
20. Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese. Bennetzen MF, Nielsen TS, Paulsen SK, Bendix J, Fisker S, Jessen N, Lund S, Richelsen B, Pedersen SB, Eur J Clin Invest 2010 40 121 6 10.1111/j.1365-2362.2009.02231.x 20039929
21. The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. Pagano C, Pilon C, Calcagno A, Urbanet R, Rossato M, Milan G, Bianchi K, Rizzuto R, Bernante P, Federspil G, Vettor R, J Clin Endocrinol Metab 2007 92 4810 9 10.1210/jc.2007-0768 17785353
22. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodríguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D, Nature 2003 425 6953 90 3 10.1038/nature01921 12955147
23. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Lauffer LM, Iakoubov R, Brubaker PL, Diabetes 2009 58 5 1058 66 10.2337/db08-1237 19208912
24. Receptors for acylethanolamides-GPR55 and GPR119. Godlewski G, Offertáler L, Wagner JA, Kunos G, Prostaglandins Other Lipid Mediat 2009 89 3-4 105 11 19615459
25. Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise. You T, Disanzo BL, Wang X, Yang R, Gong D, Lipids Health Dis 2011 10 194 10.1186/1476-511X-10-194 22035053
26. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 1640 5 10.1161/CIRCULATIONAHA.109.192644 19805654
27. Measurement Techniques in Anthropometry. Norton K, Olds T, Anthropometrica Sydney: Anthropometrica. UNSW Press, Norton K, Olds T, 1996
28. Metabolism of isolated fat cells. Rodbell M, J Biol Chem 1964 239 375 380 14169133
29. A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. Boldrup L, Wilson SJ, Barbier AJ, Fowler CJ, J Biochem Biophys Meth 2004 60 171 177 10.1016/j.jbbm.2004.04.020 15262451